HHC
CSII

Hutchin Hill Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Hutchin Hill Capital’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,600
Closed -$1.43M – 1093
2017
Q1 		$1.43M Buy
+50,600
New +$1.34M 0.04% 397

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hutchin Hill Capital's CSII Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2017, closing a stake of 50,600 shares — an estimated $1.43M sold.

Hutchin Hill Capital first reported a position in CSII in Q1 2017 and held it in 1 quarter. The position peaked at $1.43M in Q1 2017. 157 funds tracked by Wall St. Rank hold CSII as of Q2 2017.

  • Hutchin Hill Capital reported no remaining Cardiovascular Systems, Inc. position as of Q2 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 50,600 Cardiovascular Systems, Inc. shares in Q2 2017, an estimated $1.43M.
  • Hutchin Hill Capital first reported a position in Cardiovascular Systems, Inc. in Q1 2017 and held it in 1 quarter.
  • Hutchin Hill Capital's Cardiovascular Systems, Inc. position peaked at $1.43M in Q1 2017.
  • 157 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.